Jason A. Keyes

Companies

• BlossomHill Therapeutics, Inc.Chief financial officer Aug 6, 2026 to now¹
• ACTUATE THERAPEUTICS, INC.Board member Aug 12, 2024 to now²
• Equillium, Inc.Chief financial officer Oct 11, 2018 to now³
• Carisma Therapeutics Inc.Board member Feb 26, 2020 to Jun 24, 2022⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• EEquillium, Inc. EQ126,633 shares⁵$150.7K at $1.19Jan 24, 2025
• BTBlossomHill Therapeutics, Inc. BLSM700 shares⁶$9.8K at $13.94Aug 10, 2026
• CTCarisma Therapeutics Inc.40,000 shares⁷Jun 22, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 10, 2026Bought 700 shares at $16.00 of BlossomHill Therapeutics, Inc.⁶
• Jan 23, 2025Sold 10,000 shares at $0.65 of Equillium, Inc.⁵
• Dec 10, 2024Granted 15,000 shares at $0.54 of Equillium, Inc.⁸
• Nov 14, 2024Sold 10,000 shares at $0.70 of Equillium, Inc.⁹
• Sep 26, 2024Sold 10,000 shares at $0.81 of Equillium, Inc.¹⁰
• Jul 16, 2024Sold 10,000 shares at $0.87 of Equillium, Inc.¹¹
• Dec 8, 2023Granted 8,805 shares at $0.58 of Equillium, Inc.¹²
• Jun 9, 2023Granted 15,000 shares at $0.56 of Equillium, Inc.¹²
• Dec 9, 2022Granted 4,444 shares at $1.19 of Equillium, Inc.¹³
• Aug 29, 2022Sold 7,000 shares at $2.83 of Equillium, Inc.¹⁴
• Jun 22, 2022Granted 40,000 shares of Carisma Therapeutics Inc.⁷
• Jun 6, 2022Sold 5,000 shares at $2.52 of Equillium, Inc.¹⁵
• Apr 4, 2022Sold 8,000 shares at $3.18 of Equillium, Inc.¹⁶
• Dec 10, 2021Granted 5,585 shares at $2.35 of Equillium, Inc.¹⁷
• Dec 1, 2021Sold 5,000 shares at $5.08 of Equillium, Inc.¹⁸